Azithromycin use for common acute respiratory infections during a Mycoplasma pneumoniae national surge: results from the SHARPS-OP benchmarking collaborative | Synapse
Azithromycin use for common acute respiratory infections during a Mycoplasma pneumoniae national surge: results from the SHARPS-OP benchmarking collaborative
To analyze azithromycin use for respiratory infections coinciding with a Mycoplasma pneumoniae surge.
Benchmarking collaborative data analysis across multiple sites.
Assessment of azithromycin prescribing practices during national rise in Mycoplasma pneumoniae cases.
Increased azithromycin prescriptions noted during Mycoplasma pneumoniae surge.
Findings may indicate trends in treatment choices for acute respiratory infections.
Resumen
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.